This is a patent on freezing cord blood stem cells. This is an important patent since it is generating revenue. The company Pharmastem used this patent and several others in order to position itself in the cord blood industry. Additionally, this patent stood the test of litigation.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.